OBJECTIVES: To systematically review the evidence of the relation between smoking tobacco and HIV seroconversion and progression to AIDS. METHODS: A systematic review was undertaken of studies to look at tobacco smoking as a risk factor for either HIV seroconversion or progression to AIDS. RESULTS: Six studies were identified with HIV seroconversion as an outcome measure. Five of these indicated that smoking tobacco was an independent risk factor after adjusting for important confounders with adjusted odds ratios ranging from 1.6 to 3.5. 10 studies were identified using progression to AIDS as an end point of which nine found no relation with tobacco smoking. CONCLUSIONS: Tobacco smoking may be an independent risk factor for HIV infection although residual confounding is another possible explanation. Smoking did not appear to be related to progression to AIDS although this finding may not be true in developing countries or with the longer life expectancies seen with highly active antiretroviral therapy.
OBJECTIVES: To systematically review the evidence of the relation between smoking tobacco and HIV seroconversion and progression to AIDS. METHODS: A systematic review was undertaken of studies to look at tobacco smoking as a risk factor for either HIV seroconversion or progression to AIDS. RESULTS: Six studies were identified with HIV seroconversion as an outcome measure. Five of these indicated that smoking tobacco was an independent risk factor after adjusting for important confounders with adjusted odds ratios ranging from 1.6 to 3.5. 10 studies were identified using progression to AIDS as an end point of which nine found no relation with tobacco smoking. CONCLUSIONS:Tobacco smoking may be an independent risk factor for HIV infection although residual confounding is another possible explanation. Smoking did not appear to be related to progression to AIDS although this finding may not be true in developing countries or with the longer life expectancies seen with highly active antiretroviral therapy.
Authors: T Siraprapasiri; H M Foy; J K Kreiss; N Pruithitada; W Thongtub Journal: Southeast Asian J Trop Med Public Health Date: 1996-03 Impact factor: 0.267
Authors: D N Burns; D Hillman; J D Neaton; R Sherer; T Mitchell; L Capps; W G Vallier; M D Thurnherr; F M Gordin Journal: J Acquir Immune Defic Syndr Hum Retrovirol Date: 1996-12-01
Authors: A Chao; M Bulterys; F Musanganire; P Habimana; P Nawrocki; E Taylor; A Dushimimana; A Saah Journal: Int J Epidemiol Date: 1994-04 Impact factor: 7.196
Authors: T C Do; D Boettiger; M Law; S Pujari; F Zhang; R Chaiwarith; S Kiertiburanakul; M P Lee; R Ditangco; W W Wong; K V Nguyen; T P Merati; T T Pham; A Kamarulzaman; S Oka; E Yunihastuti; N Kumarasamy; P Kantipong; J Y Choi; O T Ng; N Durier; K Ruxrungtham Journal: HIV Med Date: 2016-08 Impact factor: 3.180
Authors: Timothy C Durazzo; Johannes C Rothlind; Valerie A Cardenas; Colin Studholme; Michael W Weiner; Dieter J Meyerhoff Journal: Alcohol Date: 2007-10-17 Impact factor: 2.405
Authors: Alana M Rojewski; Stephen Baldassarri; Nina A Cooperman; Ellen R Gritz; Frank T Leone; Megan E Piper; Benjamin A Toll; Graham W Warren Journal: Nicotine Tob Res Date: 2016-01-17 Impact factor: 4.244
Authors: Valerie Wojna; Lizbeth Robles; Richard L Skolasky; Raul Mayo; Ola Selnes; Tania de la Torre; Elizabeth Maldonado; Avindra Nath; Loyda M Meléndez; Jose Lasalde-Dominicci Journal: J Neurovirol Date: 2007-12 Impact factor: 2.643